By inhibiting HIF-1α, miR-519c can increase the sensitivity of pancreatic cancer cells to treatment, offering a potential strategy to overcome chemoresistance and enhance the effectiveness of therapies like GEM. This evidence concerns the gene HIF1A and familial pancreatic carcinoma.